ProfileGDS5678 / 1440142_s_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 2% 2% 2% 2% 2% 2% 2% 2% 2% 2% 2% 2% 2% 2% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 11.917482
GSM967853U87-EV human glioblastoma xenograft - Control 21.896982
GSM967854U87-EV human glioblastoma xenograft - Control 31.899282
GSM967855U87-EV human glioblastoma xenograft - Control 41.854022
GSM967856U87-EV human glioblastoma xenograft - Control 51.844552
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 11.930092
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 21.896212
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 31.874622
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 41.87062
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 11.886362
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 21.881372
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 31.872572
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 41.883012
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 51.8872